• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜介入治疗肥胖和糖尿病。

Endoscopic Interventions in the Treatment of Obesity and Diabetes.

机构信息

Department of Surgery & Cancer, Imperial College London, London, UK.

University College Hospital, London, UK.

出版信息

Dig Dis Sci. 2018 Jul;63(7):1694-1705. doi: 10.1007/s10620-018-5117-1.

DOI:10.1007/s10620-018-5117-1
PMID:29761253
Abstract

Obesity is a global health problem which is on the rise and is strongly associated with the development of type 2 diabetes and other comorbidities. Bariatric surgery is now an established treatment for both these conditions, leading to impressive results in weight loss and glycemic control. More recently, we have seen the development of various endoscopic devices as potential alternatives or adjuncts to bariatric surgery. In this state-of-the-art review, we outline the current landscape of endoscopic treatments available for the management of both obesity and diabetes, including the clinical evidence supporting their use, efficacy, safety, and potential mechanisms of action.

摘要

肥胖是一个全球性的健康问题,呈上升趋势,与 2 型糖尿病和其他合并症的发展密切相关。减重手术现在是这两种疾病的既定治疗方法,在减肥和血糖控制方面取得了令人瞩目的效果。最近,我们看到各种内镜设备的发展,作为减重手术的潜在替代或辅助手段。在这篇最新综述中,我们概述了目前可用于肥胖和糖尿病管理的内镜治疗方法,包括支持其使用的临床证据、疗效、安全性以及潜在的作用机制。

相似文献

1
Endoscopic Interventions in the Treatment of Obesity and Diabetes.内镜介入治疗肥胖和糖尿病。
Dig Dis Sci. 2018 Jul;63(7):1694-1705. doi: 10.1007/s10620-018-5117-1.
2
Selected Endoscopic Gastric Devices for Obesity.用于肥胖症的选定内镜胃装置
Gastrointest Endosc Clin N Am. 2017 Apr;27(2):267-275. doi: 10.1016/j.giec.2017.01.005.
3
Endoscopic Devices for Obesity.肥胖内镜治疗设备
Curr Obes Rep. 2016 Jun;5(2):251-61. doi: 10.1007/s13679-016-0217-8.
4
Endoscopic bariatric and metabolic therapies: Another tool for the management of diabetes and obesity.内镜减重代谢治疗:糖尿病与肥胖管理的另一手段。
J Diabetes. 2019 May;11(5):351-358. doi: 10.1111/1753-0407.12878. Epub 2019 Jan 3.
5
Endoscopic Bariatric Therapies.内镜减重治疗
Curr Gastroenterol Rep. 2016 Jun;18(6):26. doi: 10.1007/s11894-016-0501-5.
6
Development of Bariatric and Metabolic Endoscopy.减重与代谢内视镜学的发展。
Chin Med J (Engl). 2018 Jan 5;131(1):88-94. doi: 10.4103/0366-6999.221283.
7
Medical Devices in Obesity Treatment.肥胖症治疗中的医疗器械。
Curr Diab Rep. 2019 Aug 30;19(10):90. doi: 10.1007/s11892-019-1217-3.
8
The Use of the Overstitch for Bariatric Weight Loss.肥胖症减重中Overstitch的应用
Gastrointest Endosc Clin N Am. 2020 Jan;30(1):115-128. doi: 10.1016/j.giec.2019.08.005. Epub 2019 Oct 14.
9
Endoluminal weight loss and metabolic therapies: current and future techniques.腔内减重和代谢治疗:当前和未来的技术。
Ann N Y Acad Sci. 2018 Jan;1411(1):36-52. doi: 10.1111/nyas.13441. Epub 2017 Sep 8.
10
Small Bowel Target Devices and Techniques.小肠靶向设备与技术。
Gastrointest Endosc Clin N Am. 2017 Apr;27(2):289-297. doi: 10.1016/j.giec.2017.01.001.

引用本文的文献

1
Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events.通过十二指肠消融和 GLP-1RA 消除 2 型糖尿病患者的外源性胰岛素治疗可降低心血管事件风险评分。
Cardiovasc Diabetol. 2022 Sep 22;21(1):191. doi: 10.1186/s12933-022-01628-z.

本文引用的文献

1
Strategies for Reducing Population Surgical Costs in Medicare: Local Referrals to Low-cost Hospitals.降低医疗保险人口手术费用的策略:向低成本医院进行本地转诊。
Ann Surg. 2018 May;267(5):878-885. doi: 10.1097/SLA.0000000000002340.
2
Assessment of Weight Loss With the Intragastric Balloon in Patients With Different Degrees of Obesity.不同肥胖程度患者使用胃内球囊进行体重减轻的评估。
Surg Laparosc Endosc Percutan Tech. 2017 Aug;27(4):e83-e86. doi: 10.1097/SLE.0000000000000440.
3
Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes.
采用无切口磁吻合系统的部分空肠分流术:肥胖和糖尿病患者的 1 年中期结果。
Gastrointest Endosc. 2017 Nov;86(5):904-912. doi: 10.1016/j.gie.2017.07.009. Epub 2017 Jul 14.
4
Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up.内镜下袖状胃成形术治疗肥胖症:一项对248例患者进行24个月随访的多中心研究。
Obes Surg. 2017 Oct;27(10):2649-2655. doi: 10.1007/s11695-017-2693-7.
5
Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.水热十二指肠黏膜重塑:在代谢性疾病治疗中的作用
Gastrointest Endosc Clin N Am. 2017 Apr;27(2):299-311. doi: 10.1016/j.giec.2016.12.002.
6
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.减肥手术与强化药物治疗糖尿病——5年结果
N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869.
7
The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.胃内球囊对肥胖相关合并症的影响:一项系统评价和荟萃分析。
Am J Gastroenterol. 2017 Mar;112(3):429-439. doi: 10.1038/ajg.2016.530. Epub 2017 Jan 24.
8
Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study.Elipse,首款无程序控制的减肥胃气球:一项前瞻性、观察性、开放性、多中心研究。
Endoscopy. 2017 Feb;49(2):154-160. doi: 10.1055/s-0042-119296. Epub 2016 Dec 12.
9
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.用于治疗II级和III级肥胖的经皮胃造口装置:一项随机对照试验的结果
Am J Gastroenterol. 2017 Mar;112(3):447-457. doi: 10.1038/ajg.2016.500. Epub 2016 Dec 6.
10
Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss.十二指肠黏膜消融作为2型糖尿病血糖控制策略:营养信号传导或单纯体重减轻的作用
Diabetes Care. 2016 Dec;39(12):2108-2110. doi: 10.2337/dc16-1611.